Russo I, Cazzolla S, Pampaloni F, Alaibac M. Omalizumab for the treatment of chronic spontaneous urticaria: association between body mass index and outcome. Dermatol Pract Concept. 2022;12(4):e2022148. doi:10.5826/dpc.1204a148